Product
Bupivacaine Liposome
Aliases
Bupivacaine Liposome Injection
Name
POSIMIR
INN Name
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE
FDA Approved
Yes
4 clinical trials
3 organizations
3 indications
2 documents
Indication
Local Analgesia Via InfiltrationIndication
PainIndication
Cesarean Section ComplicationsClinical trial
A Real World Study on Local Infiltration of Bupivacaine Liposome Injection for Acute Postoperative Pain After Pediatric Orthopedic SurgeryStatus: Not yet recruiting, Estimated PCD: 2026-09-28
Clinical trial
Addition of Liposomal Bupivacaine to Standard Bupivacaine Versus Standard Bupivacaine Alone in the Supraclavicular Brachial Plexus Block: a Randomized Controlled TrialStatus: Completed, Estimated PCD: 2022-12-08
Clinical trial
Liposomal Bupivacaine With Standard Bupivacaine Versus Dexmedetomidine With Standard Bupivacaine for Supraclavicular Brachial Plexus Block in Distal Radial Fracture Surgery: a Randomized Controlled Trial.Status: Recruiting, Estimated PCD: 2026-01-31
Clinical trial
Erector Spinae Plane Block With Liposomal Bupivacaine for Post Cesarean Delivery Analgesia: A Pilot StudyStatus: Completed, Estimated PCD: 2023-11-09
Document
DailyMed Label: POSIMIROrganization
Renaissance Lakewood, LLCOrganization
Hospira, Inc.Organization
INNOCOLL PHARMACEUTICALS